Sclerosis News and Research RSS Feed - Sclerosis News and Research

Researchers seek to better understand sequence of events that leads people to develop MS

Researchers seek to better understand sequence of events that leads people to develop MS

A team of investigators at Brigham and Women's Hospital and the National Institute of Neurological Disorders and Stroke has launched a study of individuals at risk for multiple sclerosis (MS). [More]
People with traumatic brain injuries may have buildup of plaques related to Alzheimer's disease

People with traumatic brain injuries may have buildup of plaques related to Alzheimer's disease

A new study suggests that people with brain injuries following head trauma may have buildup of the plaques related to Alzheimer's disease in their brains. The research is published in the February 3, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
Natalizumab shows relapse prevention benefits over fingolimod in MS

Natalizumab shows relapse prevention benefits over fingolimod in MS

Natalizumab may be superior to fingolimod for preventing relapses during the first year of treatment in patients with relapsing–remitting multiple sclerosis, observational study findings show. [More]
To reduce skin cancer risk, Vitamin D deficient Aussies should supplement

To reduce skin cancer risk, Vitamin D deficient Aussies should supplement

Health pioneers BetterYou are advising those looking to boost their levels of the ‘sunshine vitamin’ to supplement orally as a safer alternative to lengthy UV exposure. [More]
New way of using MRI scanners to diagnose multiple sclerosis

New way of using MRI scanners to diagnose multiple sclerosis

A new way of using MRI scanners to look for evidence of multiple sclerosis in the brain has been successfully tested by researchers at The University of Nottingham and Nottingham University Hospitals NHS Trust. [More]
New study lays foundation for future gene replacement therapies to treat ALS patients

New study lays foundation for future gene replacement therapies to treat ALS patients

Scientists have demonstrated for the first time that it is possible to specifically modify gene expression in diseased upper motor neurons, brain cells that break down in ALS. [More]
Fingolimod trial INFORMS primary progressive MS strategy

Fingolimod trial INFORMS primary progressive MS strategy

Fingolimod is unable to slow disability progression or brain volume loss in patients with primary progressive multiple sclerosis, show the findings of the INFORMS study. [More]
New treatment could stop progression of ALS

New treatment could stop progression of ALS

Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, for nearly two years in one type of mouse model used to study the disease - allowing the mice to approach their normal lifespan. [More]
Immune signaling molecule in infected mothers linked to behavioral abnormalities in offspring

Immune signaling molecule in infected mothers linked to behavioral abnormalities in offspring

In 2010, a large study in Denmark found that women who suffered an infection severe enough to require hospitalization while pregnant were much more likely to have a child with autism (even though the overall risk of delivering a child with autism remained low). [More]
Brain-derived neurotrophic factor linked to slower cognitive decline in older people

Brain-derived neurotrophic factor linked to slower cognitive decline in older people

Older people with higher amounts of a key protein in their brains also had slower decline in their memory and thinking abilities than people with lower amounts of protein from the gene called brain-derived neurotrophic factor, or BDNF, according to a study published in the January 27, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
New findings offer roadmap for development of novel therapies to target common brain disorders

New findings offer roadmap for development of novel therapies to target common brain disorders

Scientists have pinpointed the cells that are likely to trigger common brain disorders, including Alzheimer's disease, Multiple Sclerosis and intellectual disabilities. [More]
10 million of us lack sunshine vitamin

10 million of us lack sunshine vitamin

Health pioneers BetterYou have welcomed the views of Nutritionist Marilyn Glenville, that ‘oil based supplements can help you get your recommended dose of vitamin D’. [More]
Study identifies potential therapeutic targets for treatment of multiple sclerosis

Study identifies potential therapeutic targets for treatment of multiple sclerosis

Treatment of multiple sclerosis (MS) and other inflammatory diseases may benefit by new findings from a study that identified potential therapeutic targets for a devastating disease striking some 2.3 million people worldwide. [More]

Perrigo closes previously announced acquisition of generic Retin-A portfolio from Matawan Pharmaceuticals

Perrigo Company plc announced today that it has completed the previously announced acquisition of a portfolio of generic dosage forms and strengths of Retin-A (tretinoin) from Matawan Pharmaceuticals, LLC. [More]
Neurocutaneous disorders affect skin, nervous system

Neurocutaneous disorders affect skin, nervous system

One of the most common genetic disorders is a condition called neurofibromatosis, which causes brown spots on the skin and benign tumors on the brain, spinal cord and other parts of the nervous system. [More]
Study shows African-Americans may not be at higher risk for second stroke

Study shows African-Americans may not be at higher risk for second stroke

Even though young African-Americans are at three times greater risk of a first stroke than their white counterparts, they may not be at a higher risk for a second stroke, according to a study published in the January 20, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology. The study is one of the first of its kind to look at race and second stroke risk. [More]
Stem cell transplantation of neurotrophic factors shows promise in ALS

Stem cell transplantation of neurotrophic factors shows promise in ALS

Mesenchymal stem cells cultured to secrete neurotrophic factors can be administered to patients with amyotrophic lateral sclerosis without lasting unwanted effects and may have clinical benefits, indicates a phase I/II safety analysis study. [More]
Researchers identify protein that could protect against toxic degeneration of cells in ALS

Researchers identify protein that could protect against toxic degeneration of cells in ALS

J. Gavin Daigle, a PhD candidate at the LSU Health New Orleans School of Graduate Studies, is the first author of a paper whose findings reveal another piece of the Amyotrophic Lateral Sclerosis (ALS) puzzle. [More]
Scientists find new way to re-engineer body’s immune system to target cancer

Scientists find new way to re-engineer body’s immune system to target cancer

Scientists have demonstrated a new way of re-engineering the body’s immune system to target cancer, paving the way for a new generation of drugs, unprecedented in safety and effectiveness. [More]
Three new genetic associations identified for primary open angle glaucoma

Three new genetic associations identified for primary open angle glaucoma

Researchers from Massachusetts Eye and Ear/Harvard Medical School and Case Western Reserve University School of Medicine have led an international effort to identify three genetic associations that influence susceptibility to primary open angle glaucoma -- the most common form of adult onset glaucoma and the leading cause of irreversible blindness in the world. [More]
Advertisement
Advertisement